Perrigo Company ( (PRGO) ) has released its Q1 earnings. Here is a breakdown of the information Perrigo Company presented to its investors.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Perrigo Company plc is a leading provider of consumer self-care products, specializing in over-the-counter health and wellness solutions. The company focuses on empowering consumers to manage their health through accessible self-care options.
In the first quarter of 2025, Perrigo reported a decline in net sales by 3.5% to $1.04 billion, primarily due to divested businesses and currency translation impacts. Despite this, the company achieved significant growth in adjusted earnings per share and operating margins, driven by a recovery in the infant formula business and strategic initiatives.
Key financial highlights include an adjusted EPS increase of 106.9% to $0.60, and an adjusted operating income rise of 57.6% to $147 million. The company’s ‘Three-S’ Plan and ‘Project Energize’ contributed to improved margins and operational efficiencies. However, sales in certain categories like Women’s Health and Digestive Health saw declines.
Looking ahead, Perrigo remains optimistic despite macroeconomic uncertainties, such as tariffs and consumer behavior changes. The company has widened its 2025 net sales growth outlook but reaffirmed other financial targets, indicating confidence in its strategic initiatives and market position.